(Q40838799)

24 September 2017

title

p53 mutations and loss of p53 function confer multidrug resistance in neuroblastoma (English)

1 reference

24 September 2017

main subject

multiple drug resistance

1 reference

5

C P Reynolds

1 reference

24 September 2017

N Keshelava

1

1 reference

24 September 2017

J J Zuo

series ordinal

2

1 reference

24 September 2017

N S Waidyaratne

series ordinal

3

1 reference

24 September 2017

T J Triche

series ordinal

4

1 reference

24 September 2017

publication date

1 December 2000

1 reference

24 September 2017

published in

Pediatric Blood Cancer

1 reference

24 September 2017

volume

35

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

563-568

1 reference

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C563%3A%3AAID-MPO15%3E3.0.CO%3B2-J

21 January 2018

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C563%3A%3AAID-MPO15%3E3.0.CO%3B2-J

p53 gene status and chemosensitivity of childhood acute lymphoblastic leukemia cells to adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C563%3A%3AAID-MPO15%3E3.0.CO%3B2-J

Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C563%3A%3AAID-MPO15%3E3.0.CO%3B2-J

Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C563%3A%3AAID-MPO15%3E3.0.CO%3B2-J

Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C563%3A%3AAID-MPO15%3E3.0.CO%3B2-J

Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C563%3A%3AAID-MPO15%3E3.0.CO%3B2-J

Synergism of buthionine sulfoximine and melphalan against neuroblastoma cell lines derived after disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C563%3A%3AAID-MPO15%3E3.0.CO%3B2-J

Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C563%3A%3AAID-MPO15%3E3.0.CO%3B2-J

Chemotherapy-induced apoptosis in melanoma cells is p53 dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C563%3A%3AAID-MPO15%3E3.0.CO%3B2-J

Low frequency of the p53 gene mutations in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C563%3A%3AAID-MPO15%3E3.0.CO%3B2-J

Concomitant p53 mutation and MYCN amplification in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C563%3A%3AAID-MPO15%3E3.0.CO%3B2-J

No TP53 mutations in neuroblastomas detected by PCR-SSCP analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C563%3A%3AAID-MPO15%3E3.0.CO%3B2-J

p53 status and the efficacy of cancer therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820001201%2935%3A6%3C563%3A%3AAID-MPO15%3E3.0.CO%3B2-J

10.1002/1096-911X(20001201)35:6<563::AID-MPO15>3.0.CO;2-J

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference